Nasdaq

Abbott Presents Positive Data for AMPLATZER Amulet Device

AbbottABT recently announced results for its AMPLATZER Amulet left atrial appendage (LAA) occlusion device in a bid to fortify its core Structural Heart business. Data was presented at EuroPCR, the ...
MassDevice

Abbott reports strong outcomes for next-gen Amulet LAA occlusion device

Abbott today announced positive early results from a study evaluating its investigational Amulet 360 left atrial appendage ...
Medscape

ASD closure device erosions: Teacup tempest or tip of the iceberg?

Rochester, MN - A case report of a patient who suffered erosion of an Amplatzer septal-occluder device (St Jude Medical) six years after it was implanted, resulting in cardiac tamponade and ...
MedCity News

STJ’s Amplatzer cardiac implant device hit with FDA safety alert

St. Jude Medical (STJ) received an FDA safety alert for its Amplatzer ASO, a minimally-invasive implantable cardiac device used to treat atrial septal defect. The problem? In one to three of every ...
TCTMD

Amplatzer Amulet LAA Closure Device Reduces Stroke Through 2 Years: Global Registry

PARIS, France—Left atrial appendage (LAA) occlusion with the Amplatzer Amulet (Abbott) reduces the risk of ischemic stroke in real-world use through 2 years, for the most part without the need for ...
Business Wire

Largest Observational Study to Date of the St. Jude Medical AMPLATZER Amulet Left Atrial Appendage Occluder Demonstrates High Implant Success and Strong Safety Profile

Initial results from more than 800 atrial fibrillation patients presented at Transcatheter Cardiovascular Therapeutics 2016 indicate the AMPLATZER™ Amulet™ LAA Occluder is a safe alternative to ...
Yahoo Finance

Abbott's Amplatzer Piccolo™ Delivery System Receives FDA Clearance and CE Mark to Optimize Procedures for Premature Babies With a Hole in the Heart

A PDA requiring treatment is present in approximately 20% of premature infants 1 ABBOTT PARK, Ill., Dec. 18, 2025 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug ...
Yahoo

Abbott secures FDA and CE Mark approvals for Amplatzer delivery system

Add Yahoo as a preferred source to see more of our stories on Google. Abbott’s range of paediatric heart treatments also includes the Masters HP 15mm mechanical heart valve. Credit: Michael Vi / ...
Benzinga.com

Abbott Recalls Amplatzer Steerable Delivery Sheath On Risk Of Air Embolism

Abbott Laboratories (NYSE:ABT) is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air bubbles (air emboli) to be introduced into patients who have procedures with this ...
Business Insider

Late-Breaking Data Shows Abbott's Amplatzer™ Amulet™ Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial ...

ABBOTT PARK, Ill., Aug. 30, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced late-breaking data from the Amulet™ LAA Occluder IDE trial, a multi-center, head-to-head study comparing the company ...
TCTMD

Study Compares 3 Different Devices for PFO Closure

While procedural complications and long-term neurological events are rare regardless of the device used for percutaneous closure of patent foramen ovale (PFO), recurrent events are reduced after ...